Wegovy vs. Saxenda: Which GLP-1 Weight Loss Injection is Better?
As demand for medical weight loss options grows, two GLP-1 receptor agonists dominate the market in 2025: Wegovy and Saxenda. Both are FDA-approved and effective, but how do they compare?
Wegovy (semaglutide) is taken weekly and has shown greater average weight loss in clinical trials. It is often preferred for patients needing long-term results with fewer injections. Wegovy also shares its active ingredient with Ozempic, a drug widely used for type 2 diabetes. Learn more in our Ozempic review.
Saxenda (liraglutide) is a daily injection that may be better for short-term use or patients who tolerate it well. Though effective, its average weight reduction is slightly lower than Wegovy. However, Saxenda still remains a popular alternative. Compare it with another GLP-1 option in our Liraglutide review.
Both drugs may cause mild side effects like nausea or vomiting, but most users report manageable symptoms. It's crucial to consult your healthcare provider before choosing a treatment. For broader context, explore our article on Semaglutide usage.
Key Differences
- Dosing: Wegovy is weekly; Saxenda is daily
- Results: Wegovy shows higher average weight loss
- Side Effects: Both drugs may cause nausea, especially early in treatment